Xavant Technology obtained FDA clearance for its Stimpod NMS460, a noninvasive neuromodulation device designed for symptomatic relief and management of chronic intractable pain. The device, which includes nerve-locating technology, transcutaneously delivers a patented pulsed radiofrequency waveform to target areas.
Xavant's noninvasive neuromodulation device wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.